INSYS Therapeutics Completes $37 Million IPO to Back Medical Marijuana Drug
5/21/2013
More...
|
Effector Therapeutics Raises $45 Million Series A to Fight Cancer Tumors
5/20/2013
More...
|
Karyopharm Therapeutics Raises $48.2 Million in Series B Financing
5/20/2013
More...
|
Esperion Therapeutics, Inc. Files for $70 Million IPO
5/16/2013
More...
|
Quintiles, Inc. (QTRN)'s $947.4M IPO to Spawn a New Billionaire
5/10/2013
More...
|
Startup Allecra Therapeutics Raises $19.5 Million Series A Financing
4/18/2013
More...
|
Portola Pharmaceuticals, Inc. Files for $115 Million IPO
4/15/2013
More...
|
Biotech Chimerix, Inc. Shines in IPO Debut as Interest Grows in Antiviral Drugs
4/12/2013
More...
|
Cleave Biosciences Adds $10 Million to Series A Financing
4/9/2013
More...
|
Biotech Receptos Files for a $86 Million IPO
4/5/2013
More...
|
Enanta Pharmaceuticals, Inc. Raises $56 Million in IPO
3/21/2013
More...
|
NABsys, Inc. Raises $20 Million From Investors
3/13/2013
More...
|
Emergence-Backed Veeva Systems, Inc. Seen Seeking $2 Billion Valuation With IPO
3/12/2013
More...
|
Omthera Pharmaceuticals, Inc. Files for a $75 Million IPO
3/11/2013
More...
|
Tesaro, Inc. Nets $91 Million
3/7/2013
More...
|
Ambit Biosciences Refiles for a $58 Million IPO
2/21/2013
More...
|
Sophiris Bio Inc. (SHS.TO) Files for a $75 Million IPO
2/19/2013
More...
|
Third Rock Ventures Launches Jounce Therapeutics With $47 Million
2/15/2013
More...
|
TetraPhase Pharmaceuticals Files for a $86 Million IPO
2/13/2013
More...
|
e-Therapeutics plc to Raise $62.7 Million
2/11/2013
More...
|
IPO Could Value Pfizer Inc. (PFE)'s Zoetis at Up to $12.5 Billion
1/21/2013
More...
|
InterMune, Inc. (ITMN) Announces Pricing of Concurrent Public Offerings of $105,000,000 Principal Amount of Convertible Senior Notes and 13,500,000 Shares of Common Stock
1/16/2013
More...
|
Onyx Pharmaceuticals, Inc. (ONXX) Announces Pricing of Public Offering of Common Stock
1/16/2013
More...
|
Aileron Therapeutics Nabs $12 Million for First-Ever Stapled Peptide Clinical Trial
1/14/2013
More...
|
Foundation Medicine Expands Series B Financing to $56 Million
1/8/2013
More...
|
Biotech Startup Transcriptic Receives $1.2 Million in Seed Funding Led by Google Ventures
12/14/2012
More...
|
Pfizer Inc. (PFE) to Launch Animal-Health Unit IPO in Early 2013
12/14/2012
More...
|
Sofinnova Ventures Raises $312 Million for Life Sciences
12/11/2012
More...
|
Fluxion Biosciences Secures $20 Million in Series B Financing
12/4/2012
More...
|
ArmaGen Technologies, Inc. Announces $17 Million Series A Financing
11/30/2012
More...
|
Intarcia Therapeutics, Inc. Secures $210 Million Financing to Fund Its Global Phase 3 Program
11/15/2012
More...
|
Cardioxyl Pharmaceuticals Raises $28 Million in Series B Financing
11/14/2012
More...
|
Pearl Therapeutics Grabs $65 Million in VC Funding, Moves COPD Drug Toward Phase III Trials
11/13/2012
More...
|
Visterra, Inc. Boosts Series A to $26 Million, Adds Bill & Melinda Gates Foundation as Investor
11/9/2012
More...
|
Abbott Laboratories (ABT) Announces Pricing of AbbVie's $14.7 Billion Private Placement Notes Offering
11/5/2012
More...
|
Puma Biotechnology Raises $138 Million in Public Offering of Common Stock
10/26/2012
More...
|
Aclaris Therapeutics Raises $21 Million in Series A Financing
10/24/2012
More...
|
Intercept Pharmaceuticals, Kythera Biopharmaceuticals Take Off in IPOs
10/12/2012
More...
|
KaloBios Pharmaceuticals, Inc. Files for IPO
10/5/2012
More...
|
Massachusetts Institute of Technology (MIT) Economist Pitches $30 Billion Cancer Megafund
10/2/2012
More...
|
Google Inc. Venture Fund Eyes Biotech Start-Ups With $1 Billion in Pocket
9/24/2012
More...
|
Startup Heart Drug Developer MyoKardia Lands $38 Million
9/20/2012
More...
|
Foundation Medicine Announces $42.5 Million Series B Financing
9/20/2012
More...
|
Selexys Pharmaceuticals Corporation Completes $23 Million Equity Financing and Signs Agreement With Novartis Pharmaceuticals Corporation (NVS) for Up to $665 Million
9/19/2012
More...
|
Intercept Pharmaceuticals Files for $75 Million IPO
9/5/2012
More...
|
Regulus Therapeutics, Inc. Files for Up to $58 Million IPO
8/20/2012
More...
|
KV Pharmaceutical Files for Chapter 11; Cites Makena Drug Woes
8/6/2012
More...
|
Burrill & Company Touts New Life Sciences Fund Worth $505 Million
8/3/2012
More...
|
Biotech Start-Up Atterocor Raises $16 Million Series A
8/3/2012
More...
|
Idenix Pharmaceuticals, Inc. (IDIX) Prices Public Offering of Common Stock
8/2/2012
More...
|
Agile Therapeutics, Inc. Raises $40 Million in a Series C Financing
7/19/2012
More...
|
Durata Therapeutics, Inc. Prices $68 Million IPO
7/19/2012
More...
|
Juventas Therapeutics, Inc. Raises $22.2 Million Series B Financing
7/16/2012
More...
|
Synageva BioPharma (GEVA) Announces $80 Million Proposed Public Offering of Common Stock
7/10/2012
More...
|
GenKyoTex S.A. Raises $26 Million for Phase II Development of Diabetic Nephropathy Drug
7/9/2012
More...
|
Tesaro, Inc. Sets Terms for $81 Million US IPO
6/20/2012
More...
|
Cytokinetics, Inc. (CYTK) Nabs $60 Million Financing
6/20/2012
More...
|
Global Blood Therapeutics, Third Rock Ventures’s First West Coast Startup, Gets $41 Million
6/14/2012
More...
|
New Firm Select BioVentures Seeks $200 Million for Biotech Deals in Sunshine State
6/13/2012
More...
|
Rhythm Drums Up $25 Million to Advance Diabetes and Obesity Drugs
6/13/2012
More...
|
Kleiner Perkins Caufield & Byers Launches New $525 Million Venture Fund
5/18/2012
More...
|
Arena Pharmaceuticals, Inc. (ARNA) Prices Public Offering of Common Stock
5/17/2012
More...
|
OncoMed Pharmaceuticals, Inc. Files for $115 Million IPO
5/14/2012
More...
|
Supernus Pharmaceuticals Announces Closing of Initial Public Offering
5/7/2012
More...
|
Savient Pharmaceuticals, Inc. (SVNT) Plummets as Hedge Fund Claims It's Bankrupt
5/2/2012
More...
|
Peter Thiel's Breakout Labs Awards Cash to 6 Ambitious Biotech Startups
4/17/2012
More...
|
Hyperion Therapeutics Files for $58 Million US IPO
4/13/2012
More...
|
Supernus Pharmaceuticals Sets Terms for $75 Million US IPO
4/12/2012
More...
|
BioVentures Closes $268 Million Life Sciences Fund
4/10/2012
More...
|
Merck Teams With Flagship to Bankroll Biotech Start-ups
4/10/2012
More...
|
GlaxoSmithKline (GSK), Johnson & Johnson (JNJ) Plot $200 Million Biotech Fund With Index Ventures
3/21/2012
More...
|
Wellcome Trust to Launch $318 Million Biotech Start-up Fund
3/21/2012
More...
|
Bellicum Pharmaceuticals, Inc. Closes $20 Million Series B Financing
3/8/2012
More...
|
Rusnano, US Fund to Invest $760 Million in Pharma Venture
3/6/2012
More...
|
4s3 Bioscience Lands $20 Million in Venture Funding
3/5/2012
More...
|
Pfizer Inc. (PFE) Mulls $3 Billion Partial IPO for Animal Healthcare Unit: Report
2/21/2012
More...
|
ChemoCentryx, Inc. Completes IPO
2/14/2012
More...
|
Ironwood Pharmaceuticals Announces Exercise of Over-Allotment Option in Public Offering of Common Stock
2/13/2012
More...
|
Celgene (CELG) Pours $15 Million Into Acetylon Pharmaceuticals, Takes "Observer" Role on Board
2/9/2012
More...
|
Radius Files IPO, Aims for $86 Million
2/7/2012
More...
|
RaNA Therapeutics, Inc. Emerges With $20.7 Million Startup Financing
1/18/2012
More...
|
Warp Drive Bio Launches With $125 Million from Third Rock Ventures, Greylock, Sanofi (France) (SAN.PA)
1/10/2012
More...
|
Elevation Pharmaceuticals Completes $30 Million Series B Financing to Advance Aerosol COPD Therapy
1/4/2012
More...
|
Acceleron Pharma Secures $30 Million Private Financing
12/28/2011
More...
|
Cell Therapeutics, Inc. (CTIC) Announces Institutional Investors Purchase $20 Million of Preferred Stock and Warrants
12/9/2011
More...
|
Forbion Capital Raises $50 Million to Invest in Health Companies
12/8/2011
More...
|
arGEN-X Raises $37 Million in Oversubscribed Series B Round
12/1/2011
More...
|
Fosun Pharma to Float up to $470 Million in Bonds
11/28/2011
More...
|
Rib-X Pharmaceuticals, Inc. Files for $80 Million IPO
11/28/2011
More...
|
Portola Pharmaceuticals, Inc. Announces Completion of $89 Million Financing
11/21/2011
More...
|
Agios Pharmaceuticals Secures $78 Million Series C Financing
11/17/2011
More...
|
Clovis Oncology (CLVS) Raises $130 Million in IPO
11/16/2011
More...
|
NewLink Genetics Raises $43.4 Million in IPO
11/11/2011
More...
|
Human Genome Sciences, Inc. (HGSI) Prices $430 Million Convertible Notes Offering
11/3/2011
More...
|
Third Rock Ventures Launches SAGE Therapeutics with $35 Million Backing
10/18/2011
More...
|
Topica Pharmaceuticals Announces Completion of $27 Million Series B Financing
10/18/2011
More...
|
Foundation Medicine Closes Expanded Series A Financing Totaling $33.5 Million; Third Rock Ventures and Google Inc. Ventures Join as Investors
10/18/2011
More...
|
Sofinnova Ventures Raises $440 Million for Biotech-Only VC Fund
10/17/2011
More...
|
Cleave Biosciences Raises $42 Million in Series A Financing for Novel Cancer Therapies
10/12/2011
More...
|
Kythera Biopharmaceuticals Raises $37.4 Million Financing
9/19/2011
More...
|
Merck & Co., Inc. (MRK) Creates a $250 Million Venture Capital Fund
9/16/2011
More...
|
InterMune, Inc. (ITMN) Announces Pricing of Concurrent Public Offerings of 4,000,000 Shares of Common Stock and $135 Million Principal Amount of Convertible Senior Notes
9/14/2011
More...
|
Valeritas Announces $150 Million Financing
9/13/2011
More...
|
Orphazyme Raises $19.6 Million in a Series A Financing Round
9/7/2011
More...
|
VIVUS, Inc. (VVUS) Adds $45.8 Million
8/24/2011
More...
|
KalVista Pharmaceuticals Launched With $13 Million Series A Funding to Develop Eye Drugs
8/23/2011
More...
|
Asymchem Laboratories, Inc. Announces $39 Million in VC Funds
8/22/2011
More...
|
Yaupon Therapeutics Inc. Secures $14.4 Million in Series D Financing
8/11/2011
More...
|
Enobia Pharma Raises US $40 Million
8/10/2011
More...
|
SARcode Pulls in $44 Million Series B Financing
7/18/2011
More...
|
DVS Sciences Raises $14.6 Million in Series A Financing to Advance Commercialization of Novel Single-Cell Analysis Technology
7/14/2011
More...
|
Verastem, Inc. Nabs $32 Million Series B Financing
7/14/2011
More...
|
Merrimack Pharmaceuticals Inc. Files $172.5 Million IPO
7/11/2011
More...
|
Zafgen Secures $33 Million Series C Financing
7/7/2011
More...
|
Tesaro, Inc. Snags Huge $101 Million Venture Round to Develop Cancer Drugs
6/21/2011
More...
|
AVEO Pharmaceuticals, Inc. (AVEO) Gets $100M in Stock Offering
6/16/2011
More...
|
ReVance Therapeutics, Inc. Announces $45 Million Financing
6/10/2011
More...
|
Intrexon Corporation Raises $100 Million for Synthetic Biology Initiatives
5/31/2011
More...
|
Rigel Pharmaceuticals, Inc. (RIGL) Pockets $130 Million in Financing, Seeks To Pick up Pfizer Inc. (PFE)'s Ball and Run With it
5/31/2011
More...
|
Celldex Therapeutics, Inc. (CLDX) Raises $31.5 Million
5/19/2011
More...
|
Quintiles, Inc. (QTRN) Seeking $2.23 Billion in Loans for Refinancing
5/11/2011
More...
|
Naurex Inc. Raises $18 Million to Advance Novel Antidepressant
5/11/2011
More...
|
Takeda Pharmaceuticals Bets on Fate Therapeutics
5/10/2011
More...
|
Delenex Therapeutics Extends CHF 30.2 Million Series A Financing Round
5/3/2011
More...
|
Amgen (AMGN) Outlines Strategy, Growth Objectives and Capital Allocation Plans
4/21/2011
More...
|
Sagene Pharmaceuticals, Inc. Prices IPO at $16 Per Share, Raises $92 Million in Gross Proceeds
4/20/2011
More...
|
Blueprint Medicines Secures $40 Million Series A Financing to Translate New Molecular Data into Personalized Cancer Treatments
4/11/2011
More...
|
US-China Based Ascletis, Inc. Raises $100 Million from Private Chinese Investors for Specialty Therapeutics Venture
4/6/2011
More...
|
Tranzyme Pharma Announces Pricing of Its Initial Public Offering, Raises $53.8M
4/4/2011
More...
|
Exelixis, Inc. (EXEL) Tacks on $23M
3/17/2011
More...
|
Solazyme, Inc. Proposes $100 Million IPO and Nasdaq Global Market Listing
3/15/2011
More...
|
Omthera Pharmaceuticals, Inc. Raises $33.9 Million in Series B Funding Led by New Enterprise Associates
3/14/2011
More...
|
Nimbus Discovery Unveils First Of Its Kind Drug Discovery Paradigm; Announces Seed Round Co-Led By Bill Gates
3/10/2011
More...
|
Aerie Pharmaceuticals, Inc. Completes $30 Million Series B Financing to Fund Further Development of Innovative Glaucoma Product Portfolio
3/7/2011
More...
|
Versartis, Inc. Completes $21 Million Series B Financing
2/16/2011
More...
|
Celgene (CELG) Announces Additional $1 Billion Share Repurchase Program
2/16/2011
More...
|
Eli Lilly and Company (LLY) to Raise Nearly $750 Million to Share Drug Development Costs
2/14/2011
More...
|
AcelRx Pharmaceuticals Prices IPO at $5, Below the Original $12-$14 Range
2/11/2011
More...
|
Fluidigm Corporation 5.6M-Share IPO Prices At $13.50; Low End Of Prior Estimate
2/10/2011
More...
|
Pharmasset, Inc. (VRUS) Prices Public Offering of Common Stock
1/21/2011
More...
|
Dendreon Corporation (DNDN) Announces Pricing of $540 Million Convertible Senior Notes Due 2016
1/14/2011
More...
|
TetraLogic Pharmaceuticals Closes $23 Million Second Tranche of Series C Financing
1/5/2011
More...
|
Genocea Biosciences Lands Massive $35M Series B Round
1/3/2011
More...
|
GlaxoSmithKline (GSK) Offers to Give National Cancer Institute Rebate If Pfizer Inc. (PFE) Cancer Drug Better in Head to Head Clinical Trial
12/29/2010
More...
|
QuantaLife Raises $17.2M in Series B Financing
12/13/2010
More...
|
Momenta Pharmaceuticals, Inc. (MNTA) Nabs $57.4M in Stock Offering
12/8/2010
More...
|
Geron Corporation (GERN) Plans to Raise $87M in Stock Sale
12/7/2010
More...
|
Genetics Instrument Maker Fluidigm Corporation Refiles for $86 million IPO
12/6/2010
More...
|
Anacor Pharmaceuticals, Inc. Completes $70 Million Initial Public Offering and Concurrent Private Placement
12/1/2010
More...
|
Sutro Biopharma Secures $36.5 Million in Series C Financing
11/17/2010
More...
|
Biotech AcelRx Pharmaceuticals Files For $86 Million IPO
11/15/2010
More...
|
Japan's Otsuka Holding Company to Raise $2.8 Billion in Record Pharma IPO
11/12/2010
More...
|
Complete Genomics, Inc. IPO Prices Below Range, Raises $54M
11/11/2010
More...
|
23andMe, Inc. Raises More Than $22 Million in Series C Financing
11/9/2010
More...
|
Pearl Therapeutics Raises $69 Million Series C Financing
10/20/2010
More...
|
Regeneron Pharmaceuticals, Inc. (REGN) Announces The Sale of 4,500,000 Shares of Common Stock
10/7/2010
More...
|
Pacific Biosciences to Raise Up to $230 Million in IPO
10/5/2010
More...
|
Celgene (CELG) Prices $1.25 Billion of Senior Unsecured Notes
10/5/2010
More...
|
Convergence Pharmaceuticals Successfully Launched out of GlaxoSmithKline (GSK) to Focus on Novel High Value Analgesics; Raised $35.4 Million
10/5/2010
More...
|
Dicerna Pharmaceuticals Closes $25 Million Series B Financing
9/29/2010
More...
|
Quark Pharmaceuticals Inc. Seeks Up to $20M IPO
9/27/2010
More...
|
immatics biotechnologies GmbH Raises EUR54 Million ($71 Million) to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio
9/21/2010
More...
|
Anacor Pharmaceuticals, Inc. Files to Sell Up To $86.3 Mln in IPO
9/13/2010
More...
|
Relypsa, Inc. Raises $70 Million in Series B Financing
9/13/2010
More...
|
Zogenix, Inc. Files for $90 Million IPO
9/9/2010
More...
|
Biopharma Company Endocyte, Inc. Files Plan For $86.3 Mln IPO
8/18/2010
More...
|
Pacific Biosciences Files For $200 Mln IPO
8/17/2010
More...
|
Cholesterol-Drug Developer Aegerion Pharmaceuticals, Inc. Revives Plan for $86.3M IPO
8/11/2010
More...
|
Hologic, Inc. (HOLX) to Receive $60 Million from Deerfield Management, to Use $30 Million of Proceeds to Prepay Outstanding Debt
8/6/2010
More...
|
Biotech Horizon Biopharm Files To Sell Up To $86.3 Mln In IPO
8/4/2010
More...
|
Epocrates Inc. Files for $75 Million IPO
7/19/2010
More...
|
Pacific Biosciences Announces $109 Million Financing
7/15/2010
More...
|
Trevena, Inc. Secures $35 Million in Series B Funding to Progress Portfolio of GPCR Biased Ligands and to Complete Phase 2 Study of TRV120027 for Acute Heart Failure
7/14/2010
More...
|
iPierian Inc. Closes $22 Million Series B Financing Led By Google Ventures
7/8/2010
More...
|
Calithera Biosciences, Inc. Closes $40 Million in Series A Financing
7/8/2010
More...
|
ReSearch Pharmaceutical Services (RPS), Inc. Files for up to $100 Million IPO
6/21/2010
More...
|
Exelixis, Inc. (EXEL) Regains Full Rights to Develop and Commercialize XL184; Bristol-Myers Squibb Company (BMY) will Make $17 Million Payment in Connection with Return of Drug
6/21/2010
More...
|
Genzyme Corporation (GENZ) Prices Private Senior Notes Offerings
6/15/2010
More...
|
Agile Therapeutics, Inc. Secures $45M in Series B Funding to Progress Lead Contraceptive Patch, AG200-15, Through NDA Filing
6/14/2010
More...
|
Castlight Health Raises $60 Million to Support Commercial Rollout
6/11/2010
More...
|
Otonomy, Inc. Closes $10 Million Series A Financing
6/11/2010
More...
|
NeuroTherapeutics Pharma Closes $43 Million Series B Financing and Adds Four New Investors
5/20/2010
More...
|
Ikaria Inc. Files for $200 Million IPO
5/14/2010
More...
|
Pharmasset, Inc. (VRUS) Publicly Offers 3.2 Million Shares Of Stock; Expects Proceeds Of $87.9 Million
5/14/2010
More...
|
Sequenom Inc. (SQNM) Restarts Down Syndrome Test; Raises $51.6 Million Alleviating Funding Fears
5/13/2010
More...
|
Gilead Sciences, Inc. (GILD) Board Approves $5 Billion Buyback
5/11/2010
More...
|
NeurogesX, Inc. (NGSX) Enters $40 Million Royalty Financing Agreement with Cowen Healthcare Royalty Partners For Qutenza(R)
4/30/2010
More...
|
Codexis, Inc. (CDXS) Announces Pricing of Initial Public Offering
4/22/2010
More...
|
Alimera Sciences (ALIM) Prices Low IPO
4/22/2010
More...
|
Amyris Biotechnologies, Inc. to Raise up to $100 Million in IPO
4/19/2010
More...
|
Tengion Inc. Completes Initial Public Offering
4/14/2010
More...
|
Nycomed Still Plans IPO
4/12/2010
More...
|
Achaogen Completes $56 Million Series C Financing
4/7/2010
More...
|
French Biotech Neovacs SA Targets 20 Million Euros in IPO
3/19/2010
More...
|
NGM Biopharmaceuticals, Inc. Raises $51 Million in Series B Financing and Appoints New Board Member
3/15/2010
More...
|
Rhythm Pharmaceuticals Announces $21 Million Series A
3/15/2010
More...
|
AVEO Pharmaceuticals, Inc. (AVEO) Announces Pricing of Its Initial Public Offering
3/12/2010
More...
|
Genetix Pharmaceuticals, Inc. Secures $35 Million in Series B Funding
3/12/2010
More...
|
Private UK Drug Firm Archimedes Pharma Raises US $100 Million; Former Enzon Pharmaceuticals, Inc. (ENZN) Head Appointed as CEO; US Commercial Operations to be Established
3/2/2010
More...
|
Fidelity-Backed Fluidigm Corporation May Delay IPO as Startup Deals Falter
2/22/2010
More...
|